ARCHIVES

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

This article is from The Cancer Letter archive.

Vol. 08 No. 40 | October 15, 1982

Download PDF Visit The Full Archive

Related Articles

Vanderbilt Wins Lung Cancer SPORE Grant.

May 18, 2001

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

In Brief: NCAB to Hear Program Review, Reports On AIDs Monoclonal Antibodies, Cancer Research at Drew

November 25, 1983

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993

NCI Cooperative Group Clinical Trials Approved

November 27, 2009